Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plettenberg

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
HIV Medicine|December 6, 2011
Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)K Arasteh, D Ward, A Plettenberg, et al.
AIDS (London, England)|October 31, 2001
Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recoveryC Hoffmann, S Tabrizian, E Wolf, et al.
HIV Clinical Trials|June 3, 2009
Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeksF Pulido, V Estrada, J G Baril, et al.
Infection|January 12, 2011
Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDSA Plettenberg, N H Brockmeyer, B Haastert, et al.
European Journal of Medical Research|April 17, 1999
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF)A Stoehr, K Arasteh, S Staszewski, et al.
European Journal of Medical Research|August 12, 2009
The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profileK Jansen, C Michalik, M Hahn, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
Streptococcal infections of the skin and mucous membranesE Tschachler, N Brockmeyer, I Effendy, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Genitourinary Medicine|June 1, 1996
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG)H Schöfer, M Imhof, E Thoma-Greber, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
HIV Medicine|December 6, 2011
Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)K Arasteh, D Ward, A Plettenberg, et al.
AIDS (London, England)|October 31, 2001
Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recoveryC Hoffmann, S Tabrizian, E Wolf, et al.
HIV Clinical Trials|June 3, 2009
Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeksF Pulido, V Estrada, J G Baril, et al.
Infection|January 12, 2011
Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDSA Plettenberg, N H Brockmeyer, B Haastert, et al.
European Journal of Medical Research|April 17, 1999
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF)A Stoehr, K Arasteh, S Staszewski, et al.
European Journal of Medical Research|August 12, 2009
The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a profileK Jansen, C Michalik, M Hahn, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2007
Streptococcal infections of the skin and mucous membranesE Tschachler, N Brockmeyer, I Effendy, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Genitourinary Medicine|June 1, 1996
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG)H Schöfer, M Imhof, E Thoma-Greber, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
Pageof 7